Understanding COVID-19 Vaccine Immunity in Tissue and Blood
The purpose of this study is to understand the effects of COVID-19 vaccines on the immune system and how the COVID-19 vaccines provide protection and induce long term memory. Adults who are receiving a COVID-19 vaccine will be invited to participate in this study.
Conditions:
🦠 COVID-19 (Coronavirus Disease 2019)
🗓️ Study Start (Actual) September 2024
🗓️ Primary Completion (Estimated) September 2029
✅ Study Completion (Estimated) September 2029
👥 Enrollment (Estimated) 10
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Palo Alto, California, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Adults 18yrs old and higher who are receiving a COVID-19 vaccine

    Exclusion Criteria:

    • * Pregnancy
    • * Patients with contraindications for lymph node biopsy
    • * Active cancer
    • * Current use of immunosuppression drugs
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 9 January 2023
  • First Submitted that Met QC Criteria 10 January 2023
  • First Posted 12 January 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 1 July 2024
  • Last Update Posted 3 July 2024
  • Last Verified July 2024